Invesaro

Stocks Health care TLRY

NASDAQ · Health care

Tilray Brands, Inc. (TLRY)

Tilray Brands, Inc. brought in $963.1M of revenue over the twelve months to August 31, 2026, up 15.9% from a year earlier. It posted a net loss of $164.2M. At August 31, 2026 it held $215M in cash against $118M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on October 8, 2026.

Free, no password. An email when TLRY files with the SEC.

Price
$2.85
-2.40% on the day · November 9, 2026
52-week range $2.49 to $15.70
Market cap
$332.1M
Revenue (last 12 months)
$963.1M
+15.9% year on year
Net margin
-17.1%

Key facts about Tilray Brands, Inc.

Net worth
Tilray Brands, Inc. has a market value (market cap) of $332.1M at the latest share price, and shareholders' equity of $1.6B on its balance sheet at August 31, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Revenue and profit
In fiscal 2026 revenue was $915.5M (+11.5% year on year), with a net loss of $121.4M. Over the 12 months to August 31, 2026: revenue $963.1M, net loss $164.2M.
Cash flow
In fiscal 2026 operations used $69.1M of cash.
Latest report
The latest periodic report (quarterly report, 10-Q) was filed with the SEC on October 8, 2026 and covers the period to August 31, 2026. Open on SEC EDGAR
Next earnings report
Tilray Brands, Inc.'s next report is expected around January 7, 2027. That is an estimate from its filing rhythm, not a date the company has announced.

What Tilray Brands, Inc. does

Tilray Brands, Inc. is registered with the SEC under industry code SIC 2833 (Medicinal Chemicals & Botanical Products). Its shares trade on NASDAQ under the ticker TLRY.

Revenue and profit by year

Revenue
FY21: $405.3M $405.3M FY21FY20: $210.5M $210.5M FY20FY21: $513.1M $513.1M FY21FY22: $628.4M $628.4M FY22FY23: $627.1M $627.1M FY23FY24: $788.9M $788.9M FY24FY25: $821.3M $821.3M FY25FY26: $915.5M $915.5M FY26
Net income
FY21: -$102.5M -$102.5M FY21FY20: -$271.1M -$271.1M FY20FY21: -$367.4M -$367.4M FY21FY22: -$476.8M -$476.8M FY22FY23: -$1.5B -$1.5B FY23FY24: -$245M -$245M FY24FY25: -$2.2B -$2.2B FY25FY26: -$121.4M -$121.4M FY26

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2026$915.5M-$63M-$121.4M-$1.09n/a
2025$821.3M-$2.3B-$2.2B-$24.56-$127.5M
2024$788.9M-$174.7M-$245M-$3.30-$60.2M
2023$627.1M-$1.4B-$1.5B-$23.50-$12.9M
2022$628.4M-$610.4M-$476.8M-$9.90-$211.3M
2021$513.1M-$132.2M-$367.4M-$13.60-$83.6M

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

Next report expected around January 7, 2027.

Estimated from its filing rhythm: 52 weeks after its report of January 8, 2026. Not a date the company has announced. See the report calendar · Earnings, quarter by quarter

Where TLRY ranks in Health care

Revenue$915.5M
#159 of 751 in Health care · Top 21%
Revenue growth+11.5%
#269 of 532 in Health care · Top 50%
Net margin-13.3%
#301 of 544 in Health care · Bottom 45%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What Tilray Brands, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. October 8, 2026
    Quarterly report10-Q · period to August 31, 2026Tilray Brands reported higher quarterly revenue of $257,147 thousand alongside a net loss of $(40,031) thousand.Revenue rose 23% to $257.1M versus the same quarter last year; diluted EPS -$0.32 versus $0.00.
  2. October 8, 2026
    Quarterly results8-KTilray Brands reported a 23% increase in first-quarter net revenue to $257.1 million and a net loss of $40.0 million.
  3. September 28, 2026
  4. September 28, 2026
  5. September 28, 2026
  6. September 18, 2026
  7. September 14, 2026
  8. August 10, 2026
  9. July 31, 2026
  10. July 28, 2026
    Annual report 10-K · period to May 31, 2026Revenue rose 11% to $915.5M versus the prior year; diluted EPS -$1.09 versus -$24.56.

Recent insider filings (Forms 3, 4 and 144): 10, the latest on August 27, 2026. Insider transactions on SEC

Insider trades

What the people running Tilray Brands, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider bought or sold shares on the open market in the last 90 days. The 16 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.

Bought (open market)
$0
last 90 days
Sold
$0
last 90 days
DateInsiderWhatSharesPriceValueFiling
August 26, 2026 Faltischek Denise MChief Strategy Officer Exercised options 58,204 - - Form 4
August 26, 2026 Faltischek Denise MChief Strategy Officer Shares withheld for tax 30,849 $4.88 $150.5K Form 4
August 26, 2026 Faltischek Denise MChief Strategy Officer Exercised options 120,017 - - Form 4
August 26, 2026 Faltischek Denise MChief Strategy Officer Shares withheld for tax 63,610 $4.88 $310.4K Form 4
August 26, 2026 Gendel MitchellGlobal General Counsel Exercised options 50,556 - - Form 4
August 26, 2026 Gendel MitchellGlobal General Counsel Shares withheld for tax 26,795 $4.88 $130.8K Form 4
August 26, 2026 Gendel MitchellGlobal General Counsel Exercised options 109,748 - - Form 4
August 26, 2026 Gendel MitchellGlobal General Counsel Shares withheld for tax 58,167 $4.88 $283.9K Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns TLRY

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

No holder of 5% or more has filed about this company in that window.

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

10 insiders reported holding 2,989,454 shares in total, about $8.5M at the last price.

HolderSharesAs of
Simon Irwin DPresident and CEO, Director 1,309,031 August 26, 2026
Looney Thomas P.Director 397,520 July 29, 2026
Faltischek Denise MChief Strategy Officer 225,047 August 26, 2026
Merton Carl AChief Financial Officer 215,556 August 26, 2026
Gendel MitchellGlobal General Counsel 200,225 August 26, 2026
Herhalt Johann MichaelDirector 195,561 July 29, 2026
Clanachan David FDirector 192,511 July 29, 2026
Persofsky RenahDirector 155,357 July 29, 2026
Cohen Steven MichaelDirector 55,542 July 29, 2026
Hopkinson David G.Director 43,104 July 29, 2026

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about TLRY

What does Tilray Brands, Inc. do?

Tilray Brands, Inc. is a company in the Health care sector, listed on NASDAQ as TLRY. Its shares trade on NASDAQ under the ticker TLRY.

What is Tilray Brands, Inc.'s net worth?

Tilray Brands, Inc. has a market value (market cap) of $332.1M at the latest share price, and shareholders' equity of $1.6B on its balance sheet at August 31, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is Tilray Brands, Inc. profitable?

No. Over the twelve months to August 31, 2026 it reported a net loss of $164.2M on revenue of $963.1M.

How much revenue does Tilray Brands, Inc. make?

Over the twelve months to August 31, 2026 Tilray Brands, Inc. reported revenue of $963.1M. That is 15.9% more than a year earlier.

When did Tilray Brands, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on October 8, 2026. It covers the period to August 31, 2026.

When is Tilray Brands, Inc.'s next earnings report?

Tilray Brands, Inc.'s next report is expected around January 7, 2027. That is an estimate from its filing rhythm, not a date the company has announced.

Similar companies

Compare TLRY with

Compare TLRY with any company

Follow TLRY

Get an email when Tilray Brands, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Free, no password. An email when TLRY files with the SEC.

Where the numbers come from

Financial figures are the values Tilray Brands, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.